source Post navigation Study Reveals Robust Benefits of Semaglutide in Protecting Against Kidney, CV Events in Patients With T2D – Drug Topics Mineralocorticoid receptor overactivation in diabetes mellitus: role of O-GlcNAc modification | Hypertension Research – Nature.com